Has Matthew Ercolani, MD received payments from drug or device companies?

Yes. Drug and device makers reported $415,817 in general payments to Matthew Ercolani, MD across 209 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Ercolani, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Ercolani, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Ercolani, MD

Urology · Venice, FLNPI 1801059894

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $368,704 of the $415,817 with a category attached, or 88.7%. Johnson & Johnson accounts for 60.7% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $359,330 and has fallen 99.8% since, to $777 in 2025. Among urology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$415,817in general payments, 2019–2025

Across 209 payments — averaging $1989.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$252K
Uromedica, Incorporated$98K
Neotract Inc.$42K
Intuitive Surgical$18K
Axonics, Inc.$2K
Medtronic$812
plus $3K from 17 others

What the payments were for

Consulting fees$13,2443%
Speaking & faculty fees$368,70489%
Travel & lodging$12,0433%
Food & beverage$9,8262%
Education$12,0003%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	15	$252,207
Uromedica, Incorporated	17	$98,157
Neotract Inc.	55	$42,392
Intuitive Surgical	26	$17,753
Axonics, Inc.	34	$1,924
Medtronic(2 entities)	23	$812
Procept Biorobotics Corporation	5	$497
KARL Storz Endoscopy-america	6	$416
Boston Scientific	8	$311
Teleflex LLC	2	$224
Histosonics, Inc.	1	$220
Potrero Medical, Inc.	2	$169
Arrow International, Inc.	1	$130
Bard Peripheral Vascular, Inc.	1	$104
Cook Medical LLC	1	$92
C. R. Bard, Inc. & Subsidiaries	2	$91
Rochester Medical Corporation	2	$86
Coloplast	2	$61
Galvanize Therapeutics, Inc	1	$55
Healthtronics Stone Solutions, LLC	1	$39
AbbVie	2	$33
Calyxo, Inc.	1	$30
Laborie Medical Technologies Corp.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ProACT$98,105
UroLift$41,960
Da Vinci Surgical System$17,278
Monarch Platform$8,415
Axonics$943
INTERSTIM$575
AquaBeam Robotic System$166
AQUABEAM SYSTEM$148
UroLift System$148
Axonics r-SNM System$125
24FR BIPLR COAG ELECTRDE, STERILE, PKG/6$110
COVERA$104

How this compares

$415,817 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.

See all urology providers in Florida →

Medicare billing

Part B allowed, 2024

$172,146

Medicare patients

508

Services billed

1,337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	11	$6,842
Tolterodine Tartrate	54	$4,957
Tamsulosin Hcl	90	$991
Bethanechol Chloride	11	$547
NitrofurantoinNitrofurantoin Macrocrystal	12	$428
Cephalexin	81	$248
Oxybutynin Chloride ErOxybutynin Chloride	11	$232
Oxybutynin Chloride	16	$139
Tramadol Hcl	69	$93
Ciprofloxacin Hcl	27	$78
Levofloxacin	18	$46

Paid to pharmacies, not to this prescriber.

Other urology in Venice

Paul PeritoCoral Gables$3.6M
Scott SellingerTallahassee$2.3M
Mark Anthony GonzalgoMiami$1M
Edward GheilerHialeah$655K
Rolando RiveraNaples$437K
Olubayo TojuolaOrlando$283K
Juan SuarezCoral Gables$276K
Michael McDonaldCelebration$272K
Raymond PakJacksonville$251K
Christopher WestGainesville$246K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →